Non-invasive assessment of ulcerative colitis activity when choosing a treatment regimen

In recent decades, there has been a steady increase in the incidence of ulcerative colitis worldwide. The purpose work was to analyze literature data on modern features treatment colitis, as well present our own results and cases from practice. Mesalazine remains mainstay remission often its induction patients with colitis. Currently, nature is determined by target level remission. fact onset endoscopic known occur much later than subjective clinical improvement. years, this provision supplemented evidence delay histological, laboratory (fecal calprotectin) transmural endoscopic. There increasing that duration quality depends depth When using ultrasound, it not difficult urgently assess activity prevalence inflammation parameters intestinal wall. Together fecal calprotectin, information may be key choice induction, escalation, maintenance or de-escalation options. Of course, examination colon biopsy necessary planned component management patient are 3 practice which achievement carried out during mesalazine. possibility monitoring inflammatory process help ultrasound wall clearly demonstrated. According study, found high disease according scale Doppler mapping (Limberg 4), an erosive-ulcerative recorded all (Mayo 3). Detection normal echogram accompanied absence 0) minimal manifestations 1).